Systemic Treatments for Adult Patients with Moderate-to-Severe Psoriasis: Consensus Statements for the United Arab Emirates
Anwar Al Hammadi1, *, Muna Al Murrawi2, Huda R. Ali3, Ashraf M. Reda4, Hussein A. Dayem5, Jawaher Alnaqbi6, Zaidoon Abdelhadi7, Samir Hantirah8, Ayman Alnaeem9, Fatima Al. Marzooqi10, Amani Alfalasi11, Fatima Albreiki12, Khadija Aljefri1, Faiza Al Ali13
1 DermaMed Clinic, Dubai, UAE
2 Dr. Muna Al murrawi Medical Center, Abu Dhabi, UAE
3 SEHA – Ambulatory Healthcare Services, Al Maqtaa Healthcare Center, Abu Dhabi, UAE
4 Mediclinic Welcare Hospital, Dubai, UAE
5 Mediclinic Al Noor Hospital, Abu Dhabi, UAE
6 Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE
7 Sheikh Khalifa Medical City, Abu Dhabi, UAE
8 American Hospital, Dubai, UAE
9 Ibrahim Bin Hamad Obaidullah Hospital, Emirates Health Services Establishment, Ras al Khaimah, UAE
10 Zayed Military Hospital, Abu Dhabi, UAE
11 Rashid Hospital, Dubai Health Authority, Dubai, UAE
12 Tawam Hospital, Abu Dhabi, UAE
13 Al-Qassimi Hospital, Ministry of Health and Prevention, Sharjah, UAE
Psoriasis is a chronic, immune-mediated disease characterized by mild localized plaques to severe plaques involving any part of the skin; it has a pronounced effect on patients’ quality of life. In the United Arab Emirates (UAE), there are limited local guidelines for the management of patients with psoriasis in daily clinical practice.
The study aimed to develop consensus statements for the evaluation and management of moderate-to-severe psoriasis in the UAE.
To develop consensus statements, the Emirates Dermatology Society set up advisory board meetings in which local key opinion leaders (KOLs), including dermatologists from the UAE, participated. A targeted literature review was conducted to review current international and regional guidelines on the management of psoriasis, based on which the statements were formulated. A final consensus on each statement was reached based on collective agreement among the KOLs.
Consensus statements were generated with the intention of supporting physicians in clinical decision-making with respect to the classification of disease severity, treatment options including biologic and non-biologic systemic therapies, transitioning and adjusting of systemic therapies, and monitoring and management of psoriasis in special populations.
These consensus statements could provide useful, practical guidance on the diagnosis and management of patients with moderate-to-severe psoriasis and would cater to the needs of physicians in the UAE.
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
* Address correspondence to this author at the DermaMed Clinic, Dubai, UAE; Tel: +971 4 385 2222; E-mail: firstname.lastname@example.org
Abdullah Shehab Emirates Cardiac Society Emirates Medical Association Dubai (United Arab Emirates) Biography
Biography of Abdullah Shehab
Dr. Abdullah Shehab has 22 years of experience in Internal medicine, cardiology and interventional cardiology and medical education. Currently, he serves as the General Secretary of Emirates Cardiac Society and Vice President of Gulf Intervention Society. He is a Fellow of royal college of physicians UK, American college of physician, European society of cardiology, American college of cardiology, American society of cardiac intervention and fellow of the American heart association. Professor Shehab is the Chief Editor of Emirates Medical Journal and also serves as Editor in many other regional and international journals. Dr. Shehab has published 149 paper in Medline. His research interest includes: Heart failure, Coronary artery disease, Dyslipidaemia, Hypertension, Arrhythmias, Cardiac intervention, Cardiac imaging, Screening for cardiac disease in sport players, cardiovascular disease in pregnancy.